BNP Paribas Financial Markets
HPTX

BNP Paribas Financial Markets’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-316
Closed -$14.5K – 3745
2015
Q1 		$14.5K Buy
+316
New +$9.45K ﹤0.01% 2539
2014
Q4 		– Sell
-1,081
Closed -$27.3K – 4030
2014
Q3 		$27.3K Buy
+1,081
New +$26.8K ﹤0.01% 2953
2014
Q1 		– Sell
-108
Closed -$2.18K – 4152
2013
Q4 		$2.18K Buy
+108
New +$2.54K ﹤0.01% 3623

BNP Paribas Financial Markets's HPTX Position: Q2 2015 in Review

BNP Paribas Financial Markets sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 316 shares — an estimated $14.5K sold.

BNP Paribas Financial Markets first reported a position in HPTX in Q4 2013 and held it in 3 quarters. The position peaked at $27.3K in Q3 2014. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • BNP Paribas Financial Markets reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 316 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $14.5K.
  • BNP Paribas Financial Markets first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q4 2013 and held it in 3 quarters.
  • BNP Paribas Financial Markets's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $27.3K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.